Strategy Asset Managers LLC bought a new position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,108 shares of the medical equipment provider’s stock, valued at approximately $344,000. A number of other […]
Cetera Investment Advisers increased its position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 7.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,907 shares of the medical equipment provider’s stock after purchasing an additional 1,403 shares during the […]
Brokerages forecast that Boston Scientific Co. (NYSE:BSX – Get Rating) will post sales of $2.95 billion for the current quarter, Zacks reports. Seven analysts have provided estimates for Boston Scientific’s earnings, with the highest sales estimate coming in at $3.06 billion and the lowest estimate coming in at $2.92 billion. Boston Scientific reported sales of […]
Wall Street analysts forecast that Boston Scientific Co. (NYSE:BSX – Get Rating) will announce sales of $2.95 billion for the current quarter, according to Zacks. Seven analysts have made estimates for Boston Scientific’s earnings, with the highest sales estimate coming in at $3.06 billion and the lowest estimate coming in at $2.92 billion. Boston Scientific […]
Cullinan Associates Inc. lifted its holdings in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 277.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,400 shares of the medical equipment provider’s stock after purchasing an additional 15,000 shares during the quarter. Cullinan […]